EyePoint, Inc. (EYPT)
4.685
-0.10
(-2.19%)
USD |
NASDAQ |
Sep 03, 12:10
EyePoint Cash from Investing (Quarterly) : 75.10M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.10M |
| March 31, 2026 | 59.05M |
| December 31, 2025 | -74.67M |
| September 30, 2025 | 55.38M |
| June 30, 2025 | 48.34M |
| March 31, 2025 | 39.52M |
| December 31, 2024 | -95.96M |
| September 30, 2024 | 16.20M |
| June 30, 2024 | -160.40M |
| March 31, 2024 | 20.81M |
| December 31, 2023 | -47.15M |
| September 30, 2023 | -1.72M |
| June 30, 2023 | 13.47M |
| March 31, 2023 | 32.09M |
| December 31, 2022 | 32.92M |
| September 30, 2022 | 6.272M |
| June 30, 2022 | -0.012M |
| March 31, 2022 | -56.44M |
| December 31, 2021 | -32.96M |
| September 30, 2021 | -0.131M |
| June 30, 2021 | -0.025M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.192M |
| September 30, 2020 | -0.128M |
| June 30, 2020 | -0.026M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.016M |
| December 31, 2019 | -0.006M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.025M |
| March 31, 2019 | -0.182M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| June 30, 2017 | 2.374M |
| March 31, 2017 | 3.335M |
| December 31, 2016 | 2.388M |
| September 30, 2016 | 5.48M |
| June 30, 2016 | -5.321M |
| March 31, 2016 | 1.433M |
| December 31, 2015 | -0.028M |
| September 30, 2015 | -0.546M |
| June 30, 2015 | -0.885M |
| March 31, 2015 | -2.783M |
| December 31, 2014 | -3.058M |
| September 30, 2014 | -0.007M |
| June 30, 2014 | -0.421M |
| March 31, 2014 | -2.264M |
| December 31, 2013 | 1.309M |
| September 30, 2013 | 1.442M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -3.367M |
| Eli Lilly & Co. | -15.40B |
| Elanco Animal Health, Inc. | -110.00M |
| Amylyx Pharmaceuticals, Inc. | -149.80M |
| Nuvation Bio, Inc. | 5.991M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.35M |
| Cash from Financing (Quarterly) | 19.99M |
| Free Cash Flow | -271.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7343 |
| Free Cash Flow to Equity (Quarterly) | -63.60M |
| Free Cash Flow to Firm (Quarterly) | -63.55M |
| Free Cash Flow Yield | -71.10% |